Form 8-K - Current report:
SEC Accession No. 0001555280-23-000245
Filing Date
2023-11-02
Accepted
2023-11-02 07:05:17
Documents
14
Period of Report
2023-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zts-20231102.htm   iXBRL 8-K 32718
2 EX-99.1 exhibit99q32023.htm EX-99.1 769483
6 zoetisca04a01a01a01a01a18.jpg GRAPHIC 141181
  Complete submission text file 0001555280-23-000245.txt   1167200

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zts-20231102.xsd EX-101.SCH 1967
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zts-20231102_lab.xml EX-101.LAB 24134
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zts-20231102_pre.xml EX-101.PRE 12574
8 EXTRACTED XBRL INSTANCE DOCUMENT zts-20231102_htm.xml XML 2695
Mailing Address 10 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 10 SYLVAN WAY PARSIPPANY NJ 07054 973-822-7000
Zoetis Inc. (Filer) CIK: 0001555280 (see all company filings)

EIN.: 460696167 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35797 | Film No.: 231370022
SIC: 2834 Pharmaceutical Preparations